Given the impact and sometimes confusing presentation of preeclampsia, there is an ongoing need to spread awareness and improve understanding about the condition – even within the medical community.
All pregnancies are at risk of preeclampsia. Yet some healthcare providers may overlook symptoms that suggest preeclampsia because they are also hallmarks of a normal pregnancy, or their patients may not report symptoms for fear of over-reacting. Something as simple as a headache could be a symptom of underlying and life-threatening preeclampsia.
Our research shows that fewer than one-half of well-educated women are informed of the signs and symptoms of preeclampsia and yet, in many settings, the expectant mother or somebody close to her could be the first responder to any symptoms. These findings do not bode well for women with lower literacy or who do not receive regular prenatal care. The Preeclampsia Foundation urges health care providers to ensure they and their patients properly understand the signs of preeclampsia. Only through adequate knowledge and diligent follow through, can we move women to care earlier and thus alleviate the worst of the adverse outcomes.
To that purpose, the Preeclampsia Foundation offers free patient education materials in our Marketplace to increase provider access to thorough and scientifically-vetted patient education materials.
Diagnostic criteria and management practices vary across the globe based on availability of resources, diversity amongst expert opinions, and development of country-specific guidelines. We hope you will find the resources on this page informative and helpful, and recommend you share them as appropriate with your colleagues and patients. Inclusion of these materials does not constitute an endorsement on the part of the Preeclampsia Foundation, although every effort has been made to include materials that have been most widely accepted by professional medical societies.
HELLP Syndrome DVD
The Preeclampsia Foundation presents this informative DVD to help physicians, nurses and allied health care professionals understand the biologic background and clinical implications of HELLP syndrome, a particularly dangerous, though less common, variant of preeclampsia. Dr. Judith Hibbard and two HELLP syndrome survivors – Johanna Aiken and Jill Siegel – join forces to provide a thorough explanation of HELLP syndrome. Dr. Hibbard, a board-certified Maternal-Fetal Medicine specialist, provides a cogent scientific and medical description, interspersed with real life case studies provided by the women who survived their harrowing experiences with HELLP syndrome. This 48-minute video provides 1.0 Continuing Education Credit Hours with completion of enclosed registration and evaluation forms (additional fees apply). Purchase on our marketplace.
The inspiration for the development of this course came from a meeting organised by EngenderHealth and the University of Oxford in 2007 attended by groups and individuals interested in improving global maternal health. Subsequently, the University of Oxford offered to produce an e-learning module for the management of pre-eclampsia/eclampsia, with the goal of ensuring that lack of knowledge should never be a reason for sub-optimal management of patients. The production of this course has been generously funded by the MacArthur Foundation through EngenderHealth, and developed by a group of healthcare professionals, led by Stephen Kennedy, José Villar and Catriona Murray (from the Nuffield Department of Obstetrics & Gynaecology at the University of Oxford) between March 2009 and March 2010.
If you have completed both the basic and advanced levels and would like to take the knowledge assessment test, please click on the following link: http://www.gfmer.ch/globalvoiceseclampsia/assessment.hm. All participants who correctly answer at least 15 of the 20 multiple choice questions are entitled to a course certificate jointly signed by the Nuffield Department of Obstetrics & Gynaecology at the University of Oxford and GFMER.
La inspiración para el desarrollo de este curso proviene de una reunión organizada por EngenderHealth y la Universidad de Oxford en 2007 con la participación de grupos e individuos interesados en mejorar la salud materna global. Subsecuentemente, la Universidad de Oxford se ofreció a presentar un módulo de aprendizaje electrónico para el manejo de la Preclampsia/eclampsia, con el objetivo de asegurar que la falta de conocimiento no debe ser una razón para un manejo subóptimo de los pacientes. La producción de este curso ha sido generosamente financiado por la Fundación MacArthur a través de EngenderHealth, y desarrollado por un grupo de profesionales de la salud, dirigido por Stephen Kennedy, José Villar y Catriona Murray (del Departamento Nuffield de Obstetricia y Ginecología de la Universidad de Oxford) entre Marzo 2009 y Marzo 2010.
Si ha completado el nivel básico y avanzado y quiere tomar el examen de evaluación de sus conocimientos, haga clic en http://www.gfmer.ch/globalvoiceseclampsia/evaluacion.htm. Todos los participantes que respondan correctamente al menos 15 de las 20 preguntas tendrán derecho a un certificado otorgado por el Nuffield Department of Obstetrics & Gynaecology (NDOG) de la University of Oxford y GFMER.
An online US National Library of Medicine index of published medical papers.
International Society for the Study of Hypertension in Pregnancy (ISSHP) aims to stimulate research in the field of hypertension in pregnancy, disseminate the useful results of such research, and advance education in the field. Publishes quarterly peer-reviewed journal Pregnancy Hypertension.
North American Society for the Study of Hypertension in Pregnancy (NASSHP) exists in order to organize, promote and encourage knowledge, education and research regarding all aspects of hypertensive complications of pregnancy through the exchange of professional information related to this special area of obstetrics and maternal-fetal medicine.
Society for Maternal-Fetal Medicine
Sub-specialists in obstetrics/gynecology with advanced training and expertise in maternal and fetal healthcare, especially high-risk pregnancies.